The 2019 ACCP International Symposium, titled “Antimicrobial Resistance – From Pathogenesis to Patient Care,” will be held September 13, 2019, in London, UK. The goal of the 1-day activity is to educate and engage pharmacists in applying scientific and clinical evidence to real-world patient cases in order to optimize patient care and outcomes.
At the end of the symposium, participants should be able to:
- Discuss the evolution and current understanding of the mechanisms of antimicrobial resistance
- Evaluate the effectiveness of antimicrobial therapy for multidrug-resistant gram-positive and gram-negative pathogens
- Recommend management strategies for multidrug-resistant gram-positive and gram-negative infections
- Devise a monitoring plan to assess the efficacy and safety of antimicrobial therapy
- Apply contemporary clinical evidence to optimize health and patient outcomes
Program faculty Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS, will lead the day’s activities, appraising the most up-to-date evidence on the management of multidrug-resistant infections and engaging participants in exercises to apply the evidence to the patient cases and practice scenarios encountered in clinical practice.
| Symposium Agenda |
| 8:00 a.m. | Registration |
| 8:20 a.m. | Welcome and Introductions |
| 8:30 a.m. | Antimicrobial Resistance: Threats and Pathenogenesis |
| 10:00 a.m. | Tea Break |
| 10:30 a.m. | Multidrug-Resistant Gram-positive Infections: Evidence-Based Management and Outcomes |
| Noon | Lunch |
| 1:00 p.m. | Multidrug-Resistant Gram-negative Infections: Evidence-Based Management and Outcomes |
| 2:30 p.m. | Tea Break |
| 3:00 p.m. | Patient Cases: Applying the Evidence |
| 4:00 p.m. | Closing Remarks |
Participants will be able to earn 6.0 hours of application-based continuing pharmacy education credit. Detailed information on “Antimicrobial Resistance – From Pathogenesis to Patient Care” is available at www.accp.com/store/product.aspx?pc=INT_EDUC_PGM_19.
